CiDA ACCREDITATION

Learning Objectives

Upon completion of this activity, the physician should be able to:

Describe and apply the newest developments in surgical and interventional approaches to effectivedialysis access

Choose the most appropriate surgical or interventional treatment options for dialysis access based on clnical trials, practice patterns, experience of thought leaders.

Identify and understand and the controversial areas in dialysis access based on clinical data.

Make clinical care decisions based on current evidence and established patient care standards.

Aprreciate the complex relationship between dialysis access and cardiovascular morbidiy and consider this relationship to affect better decision making in clinical practice.

Target Audience

CIDA will be of value to Surgeons, Radiologists and Nephrologists and medical staff who care for dialysis access patients.

Accreditation

Complete Conference Management is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians

Credit Designation

Complete Conference Management designates this educational activity for a maximum of 14.25 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Note: The American Nurses Credentialing Center (ANCC) Certification Program recognizes the AMA PRA Category 1 Credits^TM. Please contact ANCC at 1-800-284-2378 for further clarification.

Disclaimer

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

Faculty Disclosure

In accordance with ACCME Accreditation requirements, faculty are required to disclose any financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed during this educational activity and with any commercial supporters of this activity.

Unlabeled and Unapproved Products and/or Procedures

Faculty at this activity may discuss information about pharmaceutical agents and/or devices and/or procedures that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications, devices and procedures. If you have questions, contact the medical affairs department of the manufacturer for